138 related articles for article (PubMed ID: 36208152)
1. Positive antiphospholipid antibodies and pulmonary embolism in a patient with adalimumab-induced lupus.
Uehara M; Matsushita S; Aochi S; Yamamoto M
Mod Rheumatol Case Rep; 2023 Jan; 7(1):68-73. PubMed ID: 36208152
[TBL] [Abstract][Full Text] [Related]
2. Digital ischaemia secondary to adalimumab-induced antiphospholipid syndrome.
Cheemalavagu S; McCoy SS; Knight JS
BMJ Case Rep; 2020 Feb; 13(2):. PubMed ID: 32041760
[TBL] [Abstract][Full Text] [Related]
3. De novo Anti-TNF-α-induced Congestive Heart Failure in a Patient With Turner Syndrome and Crohn's Disease.
Keating E; Kelleher TB; Lahiff C
Inflamm Bowel Dis; 2020 Nov; 26(12):e161-e162. PubMed ID: 32619005
[No Abstract] [Full Text] [Related]
4. Pulmonary thromboembolism as the initial manifestation in a child with antiphospholipid syndrome in the emergency department.
Bhat MA; Qureshi UA; Ali SW; Bhat JI; Din N; Robbani I
Pediatr Emerg Care; 2011 Mar; 27(3):205-7. PubMed ID: 21378521
[TBL] [Abstract][Full Text] [Related]
5. Right atrial thrombus mimicking myxoma with pulmonary embolism in a patient with systemic lupus erythematosus and secondary antiphospholipid syndrome.
Cianciulli TF; Saccheri MC; Redruello HJ; Cosarinsky LA; Celano L; Trila CS; Parisi CE; Prezioso HA
Tex Heart Inst J; 2008; 35(4):454-7. PubMed ID: 19156241
[TBL] [Abstract][Full Text] [Related]
6. Predictors of anti-TNF treatment failure in anti-TNF-naive patients with active luminal Crohn's disease: a prospective, multicentre, cohort study.
Kennedy NA; Heap GA; Green HD; Hamilton B; Bewshea C; Walker GJ; Thomas A; Nice R; Perry MH; Bouri S; Chanchlani N; Heerasing NM; Hendy P; Lin S; Gaya DR; Cummings JRF; Selinger CP; Lees CW; Hart AL; Parkes M; Sebastian S; Mansfield JC; Irving PM; Lindsay J; Russell RK; McDonald TJ; McGovern D; Goodhand JR; Ahmad T;
Lancet Gastroenterol Hepatol; 2019 May; 4(5):341-353. PubMed ID: 30824404
[TBL] [Abstract][Full Text] [Related]
7. Concurrent Interstitial Granulomatous Dermatitis and TNF-α Antagonist-Induced Lupus Syndrome Secondary to Adalimumab for Crohn's Disease.
Adusumilli N; Aronica J; Glass F; Friedman A
J Drugs Dermatol; 2022 Nov; 21(11):1256-1257. PubMed ID: 36342727
[TBL] [Abstract][Full Text] [Related]
8. [Antiphospholipid syndrome--primary or secondary? Therapeutic problem].
Fijołek J; Wiatr E; Tomkowski W; Fijałkowska A; Wiechecka A; Jabłoński W
Pneumonol Alergol Pol; 2002; 70(1-2):87-96. PubMed ID: 12148182
[TBL] [Abstract][Full Text] [Related]
9. Atypical clinical manifestation of antiphospholipid syndrome.
Krysiak R; Kedzia A; Okopień B
Pol Arch Med Wewn; 2009; 119(1-2):99-103. PubMed ID: 19341187
[TBL] [Abstract][Full Text] [Related]
10. Pulmonary embolism, thrombocytopenia, and antiphospholipid syndrome.
Mahmud T
J Ayub Med Coll Abbottabad; 2011; 23(4):138-41. PubMed ID: 23472438
[TBL] [Abstract][Full Text] [Related]
11. Severe Attack of Henoch-Schönlein Purpura With Neurological Involvement During Adalimumab Treatment for Crohn's Disease.
Condamina M; Diaz E; Jamart C; Loget J; Durlach A; Salmon JH; Cadiot G; Viguier M
J Crohns Colitis; 2020 May; 14(4):538-542. PubMed ID: 31589303
[TBL] [Abstract][Full Text] [Related]
12. Anti-TNF Rechallenge After Infliximab Induced Lupus in Crohn's Disease.
Loebenstein M; Schulberg JD
Gastroenterology; 2020 Jun; 158(8):2069-2071. PubMed ID: 31945355
[No Abstract] [Full Text] [Related]
13. Long-term outcomes of patients with Crohn's disease who received infliximab or adalimumab as the first-line biologics.
Inokuchi T; Takahashi S; Hiraoka S; Toyokawa T; Takagi S; Takemoto K; Miyaike J; Fujimoto T; Higashi R; Morito Y; Nawa T; Suzuki S; Nishimura M; Inoue M; Kato J; Okada H
J Gastroenterol Hepatol; 2019 Aug; 34(8):1329-1336. PubMed ID: 30724387
[TBL] [Abstract][Full Text] [Related]
14. Resolutive pulmonary endarterectomy in a non-compliant patient with systemic lupus erythematosus and antiphospholipid syndrome.
Kuzenko A; Sciascia S; Silvestro E; Badiu I; Morsolini M; Rovere ME; Bertero MT
Rheumatol Int; 2013 Jul; 33(7):1889-93. PubMed ID: 22223400
[TBL] [Abstract][Full Text] [Related]
15. [Pulmonary thromboembolism and deep venous thrombosis in the antiphospholipid syndrome--case report].
Vucićević-Trobok J; Bogdanov B; Trifković M
Med Pregl; 2003; 56(1-2):85-8. PubMed ID: 12793194
[TBL] [Abstract][Full Text] [Related]
16. Lymphomatoid Papulosis Type B in a Patient with Crohn's Disease Treated with TNF-Alpha Inhibitors Infliximab and Adalimumab.
Medvecz M; Kiss N; Hársing J; Kuroli E; Hegede G; Csomor J; Kárpáti S; Marschalkó M
Acta Dermatovenerol Croat; 2019 Sep; 27(3):202-204. PubMed ID: 31542070
[TBL] [Abstract][Full Text] [Related]
17. Chronic thromboembolic pulmonary hypertension as an uncommon presentation of primary antiphospholipid syndrome.
Porres-Aguilar M; Pena-Ruiz MA; Burgos JD; Porres-Munoz M; Hughes HW
J Natl Med Assoc; 2008 Jun; 100(6):734-6. PubMed ID: 18595578
[TBL] [Abstract][Full Text] [Related]
18. Withdrawal of thiopurines in Crohn's disease treated with scheduled adalimumab maintenance: a prospective randomised clinical trial (DIAMOND2).
Hisamatsu T; Kato S; Kunisaki R; Matsuura M; Nagahori M; Motoya S; Esaki M; Fukata N; Inoue S; Sugaya T; Sakuraba H; Hirai F; Watanabe K; Kanai T; Naganuma M; Nakase H; Suzuki Y; Watanabe M; Hibi T; Nojima M; Matsumoto T;
J Gastroenterol; 2019 Oct; 54(10):860-870. PubMed ID: 31041545
[TBL] [Abstract][Full Text] [Related]
19. Antiphospholipid syndrome with pulmonary artery embolism and multiple venous thromboses.
Lee CE; Zain AA; Pang YK
Med J Malaysia; 2010 Sep; 65(3):221-3. PubMed ID: 21939173
[TBL] [Abstract][Full Text] [Related]
20. Antiphospholipid antibodies and non-thrombotic manifestations of systemic lupus erythematosus.
İlgen U; Yayla ME; Ateş A; Okatan İE; Yurteri EU; Torgutalp M; Keleşoğlu ABD; Turgay TM; Kınıklı G
Lupus; 2018 Apr; 27(4):665-669. PubMed ID: 29050535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
